L&G Healthcare Breakthrough UCITS ETF (DOCG)

Category Sector Equity Healthcare

This ETF can be held in an Investment ISA, SIPP and Investment Account




arrow-down-41.00p (-3.60%)

Prices updated at 09 Aug 2022, 16:16 BST
| Prices minimum 15 mins delay
Prices in GBX

Investment objective
The investment objective of the Fund is to provide exposure to the global healthcare technology industry. In order to achieve this investment objective, the Fund will seek to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position.


Growth of £1,000 as of 09 Aug 2022, 17:08

Trailing returns (%) as of 09 Aug 2022, 17:08

No data available

Annual performance (%)

YearThis fundSector Equity Healthcare
30 Jun 11 - 30 Jun 12--
30 Jun 12 - 30 Jun 13--
30 Jun 13 - 30 Jun 14--
30 Jun 14 - 30 Jun 15--
30 Jun 15 - 30 Jun 16--
30 Jun 16 - 30 Jun 17--
30 Jun 17 - 30 Jun 18--
30 Jun 18 - 30 Jun 19--
30 Jun 19 - 30 Jun 20-18.17
30 Jun 20 - 30 Jun 2141.9412.17
30 Jun 21 - 30 Jun 22-31.13-6.51

Morningstar category: Sector Equity Healthcare

Trailing returns (%)

YearThis fundSector Equity Healthcare
1 Day2.880.37
1 Month5.751.32
3 Months14.597.43
6 Months0.327.02
1 Year-19.12-3.20
3 Years annualised11.458.78
5 Years annualised--

Morningstar category: Sector Equity Healthcare

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.